Dina A. Tallman
FDA Investigator
- Dina A. Tallman first started conducting FDA inspections in 2021, with the last inspection in 2024. Over that time, Dina A. Tallman has conducted 45 inspections at 42 companies across 45 sites.
Get Dina Tallman's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Steen Poulsen, M.D., Aarhus N | 2024
Out of stock
FDA 483 Liana Apostolova, M.D., Indianapolis | 2024
Out of stock
FDA 483 Northern Biomedical Research, Inc., Norton Shores | 2024
Out of stock
FDA 483 Sagar Parikh, M.D., Ann Arbor | 2024
Out of stock
FDA 483 University Multiprofile Hospital for Active Treatment, Plovdiv | 2024
Out of stock
FDA 483 Indira Brar, M.D., Detroit | 2023
Out of stock
FDA 483 Covance Cru Inc, Madison | 2022
Out of stock
FDA 483 University Of Michigan - IRBMED, Ann Arbor | 2022
Out of stock
FDA 483 Donna S. Hrozencik, M.D., Canton | 2022
Out of stock
Co-Investigators (12)
- Chelsea W. Lamm, FDA Investigator
- Gene R. Gunn, FDA Investigator
- Jennifer A. Kemp, FDA Investigator
- Denise L. Burosh, FDA Investigator
- Daniel B. Bordt, FDA Investigator
- Lea Cranford, FDA Investigator
- Corrine M. Carter, FDA Investigator
- L'Oreal F. Walker, FDA Investigator
- Walker, L'Oreal F, FDA Investigator
- Andrace Deyampert, FDA Investigator
- Eric S. Pittman, FDA Investigator
- Myra K. Casey, FDA Investigator